FHTX
NASDAQ · Biotechnology
Foghorn Therapeutics Inc
$4.61
+0.08 (+1.77%)
Open$4.55
Previous Close$4.53
Day High$4.72
Day Low$4.47
52W High$6.95
52W Low$3.27
Volume—
Avg Volume187.3K
Market Cap356.39M
P/E Ratio—
EPS$-1.17
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
+528.9% upside
Current
$4.61
$4.61
Target
$28.99
$28.99
$18.54
$28.99 avg
$38.99
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 37.94M | 32.39M | 271.86M |
| Net Income | -91,185,717 | -70,059,027 | 13.33M |
| Profit Margin | -240.3% | -228.3% | 4.9% |
| EBITDA | -101,954,831 | -82,684,897 | 20.13M |
| Free Cash Flow | — | — | 11.27M |
| Rev Growth | +17.1% | +17.1% | -6.6% |
| Debt/Equity | — | — | 0.58 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |